Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy (NCT07348952) | Clinical Trial Compass
CompletedNot Applicable
Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy
Egypt60 participantsStarted 2023-09-01
Plain-language summary
The purpose of this study was to evaluate the therapeutic efficacy of two different Transcutaneous Electrical Nerve Stimulation modes in improving the pudendal neuralgia and its intractable perineal pain.
Who can participate
Age range
50 Years – 60 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients will be chosen after a routine medical examination.
* All patients will be approximately the same age (from 50-60 years old).
* All patients have chronic pudendal neuralgia post-prostatectomy surgery.
* They have not take another physical therapy electro- modality except the traditional physical therapy in the form of pelvic floor exercises.
* All of them will be non smokers and will be under own prescribed medications described by their physicians.
* The pain is located in the pudendal nerve distribution area.
* Pain intensity increased in the sitting position.
* There were no symptoms of nocturnal pain.
* Pain with no objective sensory impairment.
* Pain was relieved by diagnostic pudendal nerve block.
* Another clinical standard provides extra support to the diagnosis of pudendal neuralgia.
* Pain symptoms may be associated with sexual dysfunction.
Exclusion Criteria:
* Patients have simple tailbone, gluteus muscle or lower abdominal pain, or only paroxysmal pain, or only pruritic symptoms, and/or having imaging anomalies that may explain the symptoms.
* Patients who take anticoagulant drugs or have any coagulation disorder.
* Patients who will be unable to complete the study.
* Patients with pain, which is caused by malignant or autoimmune diseases.
* Patients with life threatening disorders as renal failure, myocardial infarction or others will be excluded from the study.
* Patients who suffering from skin diseases, diabetes, varicose ve…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.